Insmed (INSM) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $110.00 +5.32%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- Xperi Corporation (XPER) Tops Q3 EPS by 3c; Offers Guidance
- AMERCO (UHAL) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
